Page last updated: 2024-09-05

aluminum hydroxide, magnesium hydroxide, drug combination and Critical Illness

aluminum hydroxide, magnesium hydroxide, drug combination has been researched along with Critical Illness in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anselmino, M; Clark, GW; Hinder, RA; Perdikis, G; Singh, S; Welch, NT; Wilson, P1

Trials

1 trial(s) available for aluminum hydroxide, magnesium hydroxide, drug combination and Critical Illness

ArticleYear
Comparison of an intravenous bolus of famotidine and Mylanta II for the control of gastric pH in critically ill patients.
    American journal of surgery, 1993, Volume: 166, Issue:6

    Topics: Adult; Aluminum Hydroxide; Antacids; Critical Illness; Drug Combinations; Famotidine; Female; Gastric Acid; Gastric Acidity Determination; Gastric Fundus; Humans; Injections, Intravenous; Intubation, Gastrointestinal; Magnesium Hydroxide; Male; Middle Aged; Peptic Ulcer; Pyloric Antrum; Simethicone; Stomach; Stress, Physiological

1993